BioCentury
ARTICLE | Company News

BioChem, Maxim Pharmaceuticals deal

July 17, 2000 7:00 AM UTC

BCHE and MAXM's Cytovia Inc. subsidiary (San Diego, Calif.) will develop Cytovia's CV2105 series of small molecules, which activate caspase enzymes to induce apoptosis and are in late stage research ...